A 4-week, dose-ranging study comparing the efficacy, safety and tolerability of latanoprost 75, 100 and 125 μg/mL to latanoprost 50 μg/mL (xalatan) in the treatment of primary open-angle glaucoma and…

Overview of attention for article published in BMC Ophthalmology, May 2012

Altmetric Badge

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 41 Mendeley

Summary Dimensions citations

So far, Dimensions has found 16 publications that cite this research output.

16

The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.

The role of conventional and unconventional adaptive routes in lowering of intraocular pressure: Theoretical model and simulation

Article in Physics of Fluids (June 2023)

Phase 2b, Randomized, 3-Month, Dose-Finding Study of Sepetaprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: The ANGEL Study

Article in Journal of Ocular Pharmacology and Therapeutics (February 2022)

Sovesudil (locally acting rho kinase inhibitor) for the treatment of normal‐tension glaucoma: the randomized phase II study

Article in Acta Ophthalmologica (July 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.